Developing pyridazine-3-carboxamides to be CB2 agonists: The design, synthesis, structure-activity relationships and docking studies
Тип публикации: Journal Article
Дата публикации: 2017-09-01
SCImago Q1
Tоп 10% SCImago
WOS Q1
БС1
SJR: 1.152
CiteScore: 10.8
Impact factor: 6.7
ISSN: 02235234, 17683254
PubMed ID:
28651225
Organic Chemistry
Drug Discovery
General Medicine
Pharmacology
Краткое описание
Herein, we described the design and synthesis of a series of pyridazine-3-carboxamides to be CB2-selective agonists via a combination of scaffold hopping and bioisosterism strategies. The compounds were subjected to assessment of their potential activities through calcium mobilization assays. Among the tested derivatives, more than half of these compounds exhibited moderate to potent CB2 agonist activity. Six compounds showed EC50 values below 35 nM, and several derivatives also exhibited significantly enhanced potency and high selectivity at the CB2 receptor over the CB1 receptor. Specifically, compound 26 showed the highest CB2 agonist activity (EC50 = 3.665 ± 0.553 nM) and remarkable selectivity (Selectivity Index > 2729) against CB1. In addition, logPs of some representative compounds were measured to display significantly decreased values in comparison with GW842166X. Furthermore, docking simulations were conducted to explain the interaction mode of this series.
Найдено
Ничего не найдено, попробуйте изменить настройки фильтра.
Для доступа к списку цитирований публикации необходимо авторизоваться.
Топ-30
Журналы
|
1
|
|
|
Current Medicinal Chemistry
1 публикация, 10%
|
|
|
Russian Chemical Reviews
1 публикация, 10%
|
|
|
Phytomedicine
1 публикация, 10%
|
|
|
Pharmacology Biochemistry and Behavior
1 публикация, 10%
|
|
|
ChemMedChem
1 публикация, 10%
|
|
|
Arabian Journal of Chemistry
1 публикация, 10%
|
|
|
Bioorganic Chemistry
1 публикация, 10%
|
|
|
Expert Opinion on Therapeutic Patents
1 публикация, 10%
|
|
|
Synthesis
1 публикация, 10%
|
|
|
Chemical Society Reviews
1 публикация, 10%
|
|
|
1
|
Издатели
|
1
2
3
4
|
|
|
Elsevier
4 публикации, 40%
|
|
|
Bentham Science Publishers Ltd.
1 публикация, 10%
|
|
|
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 публикация, 10%
|
|
|
Wiley
1 публикация, 10%
|
|
|
Taylor & Francis
1 публикация, 10%
|
|
|
Georg Thieme Verlag KG
1 публикация, 10%
|
|
|
Royal Society of Chemistry (RSC)
1 публикация, 10%
|
|
|
1
2
3
4
|
- Мы не учитываем публикации, у которых нет DOI.
- Статистика публикаций обновляется еженедельно.
Вы ученый?
Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
Войти с ORCID
Метрики
10
Всего цитирований:
10
Цитирований c 2025:
2
(20%)
Цитировать
ГОСТ |
RIS |
BibTex
Цитировать
ГОСТ
Скопировать
Qian H. et al. Developing pyridazine-3-carboxamides to be CB2 agonists: The design, synthesis, structure-activity relationships and docking studies // European Journal of Medicinal Chemistry. 2017. Vol. 137. pp. 598-611.
ГОСТ со всеми авторами (до 50)
Скопировать
Qian H., Wang Z., Xie X., Pan Y., Li G. J., Xie X., Chen J. Developing pyridazine-3-carboxamides to be CB2 agonists: The design, synthesis, structure-activity relationships and docking studies // European Journal of Medicinal Chemistry. 2017. Vol. 137. pp. 598-611.
Цитировать
RIS
Скопировать
TY - JOUR
DO - 10.1016/j.ejmech.2017.05.060
UR - https://doi.org/10.1016/j.ejmech.2017.05.060
TI - Developing pyridazine-3-carboxamides to be CB2 agonists: The design, synthesis, structure-activity relationships and docking studies
T2 - European Journal of Medicinal Chemistry
AU - Qian, Hai-Yan
AU - Wang, Zhi-Long
AU - Xie, Xiao-Yu
AU - Pan, You-Lu
AU - Li, Gang Jian
AU - Xie, Xin
AU - Chen, Jian-Zhong
PY - 2017
DA - 2017/09/01
PB - Elsevier
SP - 598-611
VL - 137
PMID - 28651225
SN - 0223-5234
SN - 1768-3254
ER -
Цитировать
BibTex (до 50 авторов)
Скопировать
@article{2017_Qian,
author = {Hai-Yan Qian and Zhi-Long Wang and Xiao-Yu Xie and You-Lu Pan and Gang Jian Li and Xin Xie and Jian-Zhong Chen},
title = {Developing pyridazine-3-carboxamides to be CB2 agonists: The design, synthesis, structure-activity relationships and docking studies},
journal = {European Journal of Medicinal Chemistry},
year = {2017},
volume = {137},
publisher = {Elsevier},
month = {sep},
url = {https://doi.org/10.1016/j.ejmech.2017.05.060},
pages = {598--611},
doi = {10.1016/j.ejmech.2017.05.060}
}
Ошибка в публикации?